Brokers Set Expectations for Astera Labs FY2026 Earnings

Astera Labs, Inc. (NASDAQ:ALAB) – Equities research analysts at Northland Capmk issued their FY2026 earnings per share (EPS) estimates for Astera Labs in a research note issued on Thursday, January 2nd. Northland Capmk analyst G. Richard expects that the company will earn $0.71 per share for the year. Northland Capmk currently has a “Hold” rating on the stock. The consensus estimate for Astera Labs’ current full-year earnings is ($0.45) per share.

Several other equities research analysts have also recently weighed in on ALAB. Northland Securities cut Astera Labs from an “outperform” rating to a “market perform” rating and upped their target price for the stock from $100.00 to $120.00 in a report on Thursday. JPMorgan Chase & Co. raised their target price on shares of Astera Labs from $70.00 to $110.00 and gave the company an “overweight” rating in a research report on Tuesday, November 5th. Morgan Stanley increased their price objective on shares of Astera Labs from $94.00 to $142.00 and gave the company an “overweight” rating in a research note on Friday, December 20th. Stifel Nicolaus upped their target price on Astera Labs from $80.00 to $100.00 and gave the stock a “buy” rating in a report on Tuesday, November 5th. Finally, Needham & Company LLC reissued a “buy” rating and issued a $65.00 price target on shares of Astera Labs in a research report on Wednesday, October 9th. Two research analysts have rated the stock with a hold rating and eleven have given a buy rating to the company. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and an average target price of $101.58.

Astera Labs Stock Up 4.7 %

Astera Labs stock opened at $140.93 on Monday. Astera Labs has a fifty-two week low of $36.22 and a fifty-two week high of $147.36. The company has a 50 day moving average price of $109.63 and a 200-day moving average price of $71.62.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Monday, November 4th. The company reported $0.23 EPS for the quarter, topping analysts’ consensus estimates of $0.17 by $0.06. The firm had revenue of $113.10 million for the quarter, compared to analysts’ expectations of $97.50 million. Astera Labs had a negative net margin of 30.69% and a negative return on equity of 15.57%. The firm’s revenue was up 47.1% on a year-over-year basis.

Insiders Place Their Bets

In related news, CEO Jitendra Mohan sold 47,667 shares of the stock in a transaction that occurred on Friday, October 11th. The shares were sold at an average price of $70.26, for a total value of $3,349,083.42. Following the transaction, the chief executive officer now owns 728,420 shares in the company, valued at approximately $51,178,789.20. This represents a 6.14 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Manuel Alba sold 11,000 shares of the firm’s stock in a transaction that occurred on Wednesday, December 4th. The stock was sold at an average price of $117.50, for a total transaction of $1,292,500.00. Following the transaction, the director now directly owns 456,863 shares of the company’s stock, valued at $53,681,402.50. This represents a 2.35 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 1,978,119 shares of company stock valued at $186,618,509.

Institutional Trading of Astera Labs

Hedge funds and other institutional investors have recently made changes to their positions in the business. Fred Alger Management LLC boosted its holdings in Astera Labs by 1,361.0% in the third quarter. Fred Alger Management LLC now owns 2,821,921 shares of the company’s stock valued at $147,840,000 after purchasing an additional 2,628,765 shares during the last quarter. Westfield Capital Management Co. LP purchased a new stake in shares of Astera Labs in the third quarter worth about $52,049,000. The Manufacturers Life Insurance Company grew its holdings in Astera Labs by 15,477.8% during the third quarter. The Manufacturers Life Insurance Company now owns 879,055 shares of the company’s stock worth $46,054,000 after acquiring an additional 873,412 shares during the period. Spyglass Capital Management LLC purchased a new position in Astera Labs during the third quarter valued at approximately $38,565,000. Finally, State Street Corp lifted its holdings in Astera Labs by 173.1% in the third quarter. State Street Corp now owns 698,467 shares of the company’s stock valued at $36,593,000 after acquiring an additional 442,698 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Company Profile

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.